Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEPTO3: 3 vs 7 Days Antibiotics for Mild Leptospirosis
NCT04211649Phase 4Not yet recruiting
- Sponsor
- CHU de Martinique
- Start
- Oct 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of amoxicillin, doxycycline in leptospirosis, sponsored by CHU de Martinique. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
amoxicillindoxycycline
03
Conditions
leptospirosis
Beyond the preview
Go deeper on NCT04211649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04211649.